
Guests Adrian Wong, PharmD, MPH, BCCCP; and Cayley Krkljes, PharmD, BCPS, about a systematic review of phenobarbital and primidone drug-drug interactions, highlighting clinically significant risks when used with other therapies.
Hosted by Erica Marini, PharmD, Mind the Meds will examine therapies, trends, and clinical decisions shaping care for neurological conditions, as well as cover new drug approvals and key data from notable conferences and trials. Through conversations with experts, the show will bridge the gap between clinical evidence and real-world practice by addressing the patient's experience. Mind the Meds is an accessible resource for pharmacists and other health care professionals who want to stay current in the fast-moving field of neurology.

Guests Adrian Wong, PharmD, MPH, BCCCP; and Cayley Krkljes, PharmD, BCPS, about a systematic review of phenobarbital and primidone drug-drug interactions, highlighting clinically significant risks when used with other therapies.

Erica Marini, PharmD, and guest, Millad Sobhanian, PharmD, BCPS, discuss 3 major Alzheimer disease developments including a newly approved agitation therapy, the delayed FDA decision on lecanemab subcutaneous initiation dosing, and a controversial review on anti-amyloid therapies.

In this debut episode Erica Marini and her colleagues discuss the critical role pharmacists play in complex neurologic care and the latest emerging therapies and research presented at the AAN 2026 Annual Meeting.

This new podcast will explore therapies, trends, and clinical decisions shaping neurology from a pharmacist's point of view.